On Sept. 12, 2022, Edgewise Therapeutics released positive 4-month interim data from their open label study in individuals with Becker muscular dystrophy.
Read their full press release below.
- About Us
- Programs & Events
-
-
Programs
-
Events
-
-
-
-
- Resources
-
-
-
-
-
Welcome Packet
Been diagnosed or want to learn more?
Request a PacketAbout Duchenne
Facts, Treatment, and Care
Read MoreDuchenne News
The latest from our partners.
Read NowFemale Carriers
Resources, Care, and Programs
Community Ambassadors
Meet our Community Ambassadors
Clinical Trials
A quick look at investigational drug studies
-
-
-
-
-
Volunteer Opportunities
Ways to get involved and help raise funds and awareness for Duchenne.
Volunteer TodayCommunity Ambassadors
These ambassadors are Jett Foundation’s extra ears, eyes, and voice.
Toolkits
View our resources targeted toward volunteers.
Our Resources
-
-
-
-
-
Become a Partner
Learn about creating a partnership and joining our community.
Get StartedResource Library
Read about our resources for Partners.
Resources for Partners
-
-
-
-
-
How To Help
Make a difference in the lives of those living with Duchenne.
Get Started VolunteeringClinical Trials
A quick look at investigational drug studies.
Read More About Clinical TrialsDuchenne News
Stay up to date with the latest discoveries.
Read NowBook: Dan And DMD
This book will help parents and guardians as they prepare to talk to their children about Duchenne.
Read HereOur Insurance Flight Plan
Our Health Insurance Flight Plan breaks down options that may be available to you.
Request a Flight PlanResource Library
Read about our resources for Medical Professionals.
Resources for Medical Professionals
-
-
-
- Blog
- Get Involved
- Donate
- About Us
- Programs & Events
Programs
Events
- Resources
- Blog
- Get Involved
- Donate
